Found 200 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez and Sangari, F. J., “Mycobacterial invasion of epithelial cells.”, Sub-cellular biochemistry, vol. 33, pp. 231-49, 2000.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B., “Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex.”, The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.
L. E. Bermudez, Petrofsky, M., Kolonoski, P., and Young, L. S., “Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy.”, Antimicrobial agents and chemotherapy, vol. 42, no. 1, pp. 180-3, 1998.
L. E. Bermudez, Kolonoski, P., and Young, L. S., “Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.”, Antimicrobial agents and chemotherapy, vol. 40, no. 4, pp. 1033-5, 1996.
L. E. Bermudez, Wu, M., and Young, L. S., “Effect of stress-related hormones on macrophage receptors and response to tumor necrosis factor.”, Lymphokine research, vol. 9, no. 2, pp. 137-45, 1990.
L. E. Bermudez, Kolonoski, P., Seitz, L. E., Petrofsky, M., Reynolds, R., Wu, M., and Young, L. S., “SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.”, Antimicrobial agents and chemotherapy, vol. 48, no. 9, pp. 3556-8, 2004.
L. E. Bermudez, “Effect of ethanol on the interaction between the macrophage and Mycobacterium avium.”, Alcohol (Fayetteville, N.Y.), vol. 11, no. 2, pp. 69-73, 1994.
L. E. Bermudez and Young, L. S., “Oxidative and non-oxidative intracellular killing of Mycobacterium avium complex.”, Microbial pathogenesis, vol. 7, no. 4, pp. 289-98, 1989.
L. E. Bermudez and Sangari, F. J., “Cellular and molecular mechanisms of internalization of mycobacteria by host cells.”, Microbes and infection / Institut Pasteur, vol. 3, no. 1, pp. 37-42, 2001.
L. E. Bermudez and Champsi, J., “Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice.”, Infection and immunity, vol. 61, no. 7, pp. 3093-7, 1993.
L. E. Bermudez, “[Bacteremias in immunosuppressed patients].”, Revista paulista de medicina, vol. 104, no. 2, pp. 87-92, 1986.
L. E. Bermudez, Kolonoski, P., Wu, M., Aralar, P. A., Inderlied, C. B., and Young, L. S., “Mefloquine is active in vitro and in vivo against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 43, no. 8, pp. 1870-4, 1999.
L. E. Bermudez and Inderlied, C. B., “Effect of Mycobacterium avium infection on the influx, accumulation, and efflux of KRM-1648 by human macrophages.”, Microbial drug resistance (Larchmont, N.Y.), vol. 3, no. 3, pp. 277-82, 1997.
L. E. Bermudez, “Infection of "nonprofessional phagocytes" with Mycobacterium avium complex.”, Clinical immunology and immunopathology, vol. 61, no. 2 Pt 1, pp. 225-35, 1991.
L. E. Bermudez and Kaplan, G., “Recombinant cytokines for controlling mycobacterial infections.”, Trends in microbiology, vol. 3, no. 1, pp. 22-7, 1995.
L. E. Bermudez, Martinelli, J. C., Gascon, R., Wu, M., and Young, L. S., “Protection against gram-negative bacteremia in neutropenic mice with recombinant granulocyte-macrophage colony-stimulating factor.”, Cytokine, vol. 2, no. 4, pp. 287-93, 1990.
L. E. Bermudez, Kemper, C. A., and Deresinski, S. C., “Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF.”, Biotherapy (Dordrecht, Netherlands), vol. 8, no. 2, pp. 135-42, 1994.
L. E. Bermudez and Young, L. S., “Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 32, no. 8, pp. 1149-53, 1988.
L. E. Bermudez, Wagner, D., and Sosnowska, D., “Mechanisms of Mycobacterium avium pathogenesis.”, Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S., “Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.”, Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez, Petrofsky, M., and Stevens, P., “Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”, Immunology, vol. 94, no. 3, pp. 297-303, 1998.
L. E. Bermudez and Goodman, J., “Mycobacterium tuberculosis invades and replicates within type II alveolar cells.”, Infection and immunity, vol. 64, no. 4, pp. 1400-6, 1996.
L. E. Bermudez, Inderlied, C., and Young, L. S., “Stimulation with cytokines enhances penetration of azithromycin into human macrophages.”, Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez, Motamedi, N., Chee, C., Baimukanova, G., Kolonoski, P., Inderlied, C., Aralar, P., Wang, G., Phan, L. Tam, and Young, L. S., “EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.”, Antimicrobial agents and chemotherapy, vol. 51, no. 5, pp. 1666-70, 2007.
L. E. Bermudez, Young, L. S., and Inderlied, C. B., “Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”, Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.

Pages